BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 10127126)

  • 1. Baxter earnings climb 6.5%.
    Scott L
    Mod Healthc; 1993 Jul; 23(30):32. PubMed ID: 10127126
    [No Abstract]   [Full Text] [Related]  

  • 2. Baxter posts $201 million in first-quarter profits.
    Scott L
    Mod Healthc; 1993 Apr; 23(17):12. PubMed ID: 10125656
    [No Abstract]   [Full Text] [Related]  

  • 3. Baxter sees 5% drop in operating income.
    Scott L
    Mod Healthc; 1993 Jul; 23(29):15. PubMed ID: 10127091
    [No Abstract]   [Full Text] [Related]  

  • 4. Baxter officials work to minimize fallout from actions taken by VA.
    Scott L
    Mod Healthc; 1993 Aug; 23(34):6. PubMed ID: 10127813
    [No Abstract]   [Full Text] [Related]  

  • 5. Baxter reports 13% gain in 3rd-quarter earnings, excluding Caremark unit.
    Wagner M
    Mod Healthc; 1992 Oct; 22(43):16. PubMed ID: 10121645
    [No Abstract]   [Full Text] [Related]  

  • 6. Provider criticism of medical-surgical supply distributors is based on incorrect perceptions and expectations.
    Pancratz CM
    Hosp Mater Manage; 1996 Jan; 21(1):11. PubMed ID: 10154294
    [No Abstract]   [Full Text] [Related]  

  • 7. Large investors keep confidence in Baxter.
    Scott L
    Mod Healthc; 1993 May; 23(19):8. PubMed ID: 10125885
    [No Abstract]   [Full Text] [Related]  

  • 8. Baxter reports 9% rise in '95 profits.
    Moore JD
    Mod Healthc; 1996 Feb; 26(7):12. PubMed ID: 10154703
    [No Abstract]   [Full Text] [Related]  

  • 9. The new law of supplies & demands.
    Taylor KS
    Health Facil Manage; 1994 Aug; 7(8):30-2, 34, 36 passim. PubMed ID: 10136065
    [No Abstract]   [Full Text] [Related]  

  • 10. Baxter takes charge, posts big loss.
    Scott L
    Mod Healthc; 1994 Jan; 24(5):14. PubMed ID: 10131366
    [No Abstract]   [Full Text] [Related]  

  • 11. Hospitals taking another look at Owens & Minor.
    DeJohn P
    Hosp Mater Manage; 1998 Dec; 23(12):1, 9-10. PubMed ID: 10338812
    [No Abstract]   [Full Text] [Related]  

  • 12. Premier execs to discuss Baxter guilty plea.
    Wagner M
    Mod Healthc; 1993 Apr; 23(14):11. PubMed ID: 10124970
    [No Abstract]   [Full Text] [Related]  

  • 13. Loucks, Bays, air views on Baxter/AHSC combination.
    Loucks VR; Bays KD
    Med Prod Sales; 1985 Dec; 16(12):6, 42-5. PubMed ID: 10274682
    [No Abstract]   [Full Text] [Related]  

  • 14. Baxter admits mistake in boycott case.
    Wagner M
    Mod Healthc; 1993 Mar; 23(13):4. PubMed ID: 10124832
    [No Abstract]   [Full Text] [Related]  

  • 15. Biomedical diagnostics sales climb faster than hospital expenditures.
    Purch Adm; 1978 Jun; 2(5):7-9. PubMed ID: 10307370
    [No Abstract]   [Full Text] [Related]  

  • 16. Stats. A sterilization cycle. Growth patterns dependent on type.
    Ajmani D
    Mater Manag Health Care; 2002 Dec; 11(12):32. PubMed ID: 12506809
    [No Abstract]   [Full Text] [Related]  

  • 17. Managing your vendor relationships.
    Lanser EG
    Healthc Exec; 2002; 17(5):52-3. PubMed ID: 12233123
    [No Abstract]   [Full Text] [Related]  

  • 18. E-commerce then and now.
    Hosp Mater Manage; 2008 Oct; 33(10):1-4. PubMed ID: 18988466
    [No Abstract]   [Full Text] [Related]  

  • 19. VHA gives Baxter a corner on private-label distribution.
    Lutz S
    Mod Healthc; 1991 Nov; 21(46):16. PubMed ID: 10114698
    [No Abstract]   [Full Text] [Related]  

  • 20. Baxter's net income increases 28% in fourth quarter.
    Wagner M
    Mod Healthc; 1991 Jan; 21(4):14. PubMed ID: 10108752
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.